Sign inGet started

Bernstein Karen

Insider CIK 1654055 · VTAE Director · AKAO Director · OVID Director · CDAK Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OVID Ovid Therapeutics Inc. A Award deriv2026-02-262026-03-0265,000— $065,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2025-02-202025-06-1845,000— $045,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2024-12-122024-12-1690,000— $090,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2024-02-222024-02-2630,000— $030,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2023-02-232023-02-2715,000— $015,000SEC↗
CDAK Codiak BioSciences, Inc. M Exercise deriv2023-02-162023-02-218,750— $00SEC↗
CDAK Codiak BioSciences, Inc. M Exercise2023-02-162023-02-218,750— $08,750SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-06-172022-06-211,500— $01,500SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-06-172022-06-217,500— $07,500SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2022-04-082022-04-1269,424— $069,424SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-02-162022-02-188,750— $08,750SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2022-02-032022-02-0415,000— $015,000SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2021-06-182021-06-2210,000— $010,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2021-06-112021-06-1115,000— $015,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2021-05-172021-05-181,750— $01,750SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2020-10-132020-10-1510,000— $010,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2020-06-052020-06-0813,250— $013,250SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2019-11-132019-11-157,437— $07,437SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2019-06-102019-08-015,813— $05,813SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2019-06-072019-06-105,813— $05,813SEC↗
OVID Ovid Therapeutics Inc. P Buy2019-02-262019-02-2810,000$2.02 $20.2K20,000SEC↗
OVID Ovid Therapeutics Inc. P Buy2018-08-142018-08-1610,000$6.23 $62.3K10,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2018-06-072018-06-085,813— $05,813SEC↗
AKAO Achaogen Inc A Award deriv2018-06-052018-06-0715,000— $015,000SEC↗
AKAO Achaogen Inc A Award deriv2017-07-112017-07-1320,000— $020,000SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2520,000$9.99 $199.8K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2510,000$11.38 $113.8K0SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2016-05-262016-05-2710,000— $010,000SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2015-09-302015-09-3020,000— $020,000SEC↗